PRLX 93936

· Prolexys Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PRLX 93936, covering 2012-01-05 to 2013-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma [Phase 1, Phase 2]